ApprovalTrail

Approval · Notice of Compliance 4181 · 1996

AVIRAX: Notice of Compliance 4181

Issued November 20, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4181
Date
November 20, 1996
Company
Fabrigen Inc.Pierrefonds, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Admin
Reason
Changes in manufacturing, revised specifications
Therapeutic class
Antiviral agent

Products in this notice

BrandDINStatus today
AVIRAXNot yet assigned—

Medicinal ingredients